Oxycodone 5/apap 500

   
Google
 
Web NewDrugInformation.com

Oxycodone 5/apap 500


Drug - Oxycodone 5/apap 500
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Acetaminophen; Oxycodone Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 500MG;5MG
The potency of the active ingredient(s), Acetaminophen; Oxycodone Hydrochloride. May repeat for multiple part products.

Applicant - BRISTOL MYERS SQUIBB
The firm name holding legal responsibility for Oxycodone 5/apap 500. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 085911
The FDA assigned number to Oxycodone 5/apap 500. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Oxycodone 5/apap 500. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Oxycodone 5/apap 500 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Oxycodone 5/apap 500. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Oxycodone 5/apap 500 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bristol Myers Squibb Pharma Co
The full name of the firm holding legal responsibility for the new application of Oxycodone 5/apap 500.

Oxycodone 5/apap 500